![Survival outcome of non-small cell lung cancer patients: Comparing results between the database of the Comprehensive Cancer Center Zürich and the Epidemiological Cancer Registry Zurich and Zug - ScienceDirect Survival outcome of non-small cell lung cancer patients: Comparing results between the database of the Comprehensive Cancer Center Zürich and the Epidemiological Cancer Registry Zurich and Zug - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0169500220304748-gr1.jpg)
Survival outcome of non-small cell lung cancer patients: Comparing results between the database of the Comprehensive Cancer Center Zürich and the Epidemiological Cancer Registry Zurich and Zug - ScienceDirect
![Prognostic factors in resected pathological N1-stage II nonsmall cell lung cancer | European Respiratory Society Prognostic factors in resected pathological N1-stage II nonsmall cell lung cancer | European Respiratory Society](https://erj.ersjournals.com/content/erj/41/3/649/F1.large.jpg)
Prognostic factors in resected pathological N1-stage II nonsmall cell lung cancer | European Respiratory Society
![File:Overall survival in non-small lung cancer patients treated with modern immunotherapy in the first line for advanced or metastatic disease.jpg - Wikimedia Commons File:Overall survival in non-small lung cancer patients treated with modern immunotherapy in the first line for advanced or metastatic disease.jpg - Wikimedia Commons](https://upload.wikimedia.org/wikipedia/commons/5/5a/Overall_survival_in_non-small_lung_cancer_patients_treated_with_modern_immunotherapy_in_the_first_line_for_advanced_or_metastatic_disease.jpg)
File:Overall survival in non-small lung cancer patients treated with modern immunotherapy in the first line for advanced or metastatic disease.jpg - Wikimedia Commons
![Cancers | Free Full-Text | Real-World Impact of SABR on Stage I Non-Small-Cell Lung Cancer Outcomes at a Scottish Cancer Centre Cancers | Free Full-Text | Real-World Impact of SABR on Stage I Non-Small-Cell Lung Cancer Outcomes at a Scottish Cancer Centre](https://www.mdpi.com/cancers/cancers-15-01431/article_deploy/html/images/cancers-15-01431-g001.png)
Cancers | Free Full-Text | Real-World Impact of SABR on Stage I Non-Small-Cell Lung Cancer Outcomes at a Scottish Cancer Centre
Overall survival of stage IV non-small cell lung cancer patients treated with Viscum album L. in addition to chemotherapy, a real-world observational multicenter analysis | PLOS ONE
![Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment | Radiation Oncology | Full Text Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment | Radiation Oncology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs13014-022-02080-9/MediaObjects/13014_2022_2080_Fig1_HTML.png)
Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment | Radiation Oncology | Full Text
![Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis | BMC Cancer | Full Text Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis | BMC Cancer | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12885-020-06738-z/MediaObjects/12885_2020_6738_Fig3_HTML.png)
Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis | BMC Cancer | Full Text
![A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study - The Lancet Digital Health A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study - The Lancet Digital Health](https://www.thelancet.com/cms/asset/0fbe43e7-b69c-43d2-bff9-10ce650542f3/gr1.jpg)
A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study - The Lancet Digital Health
![Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis | Radiation Oncology | Full Text Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis | Radiation Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13014-019-1222-3/MediaObjects/13014_2019_1222_Fig1_HTML.png)
Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis | Radiation Oncology | Full Text
![Overall survival of 1466 non-small cell lung cancer patients according... | Download Scientific Diagram Overall survival of 1466 non-small cell lung cancer patients according... | Download Scientific Diagram](https://www.researchgate.net/publication/317189811/figure/fig3/AS:613891981709346@1523374662976/Overall-survival-of-1466-non-small-cell-lung-cancer-patients-according-to.png)
Overall survival of 1466 non-small cell lung cancer patients according... | Download Scientific Diagram
![Clinical trial shows significant disease-free survival for patients diagnosed with non-small cell lung cancer Clinical trial shows significant disease-free survival for patients diagnosed with non-small cell lung cancer](https://scx1.b-cdn.net/csz/news/800a/2023/clinical-trial-shows-s.jpg)
Clinical trial shows significant disease-free survival for patients diagnosed with non-small cell lung cancer
![Cancers | Free Full-Text | Immune Checkpoint Inhibitors after Radiation Therapy Improve Overall Survival Rates in Patients with Stage IV Lung Cancer Cancers | Free Full-Text | Immune Checkpoint Inhibitors after Radiation Therapy Improve Overall Survival Rates in Patients with Stage IV Lung Cancer](https://pub.mdpi-res.com/cancers/cancers-15-04260/article_deploy/html/images/cancers-15-04260-g001.png?1692958885)
Cancers | Free Full-Text | Immune Checkpoint Inhibitors after Radiation Therapy Improve Overall Survival Rates in Patients with Stage IV Lung Cancer
![Prognostic impact of CD8 and programmed death-ligand 1 expression in patients with resectable non-small cell lung cancer | British Journal of Cancer Prognostic impact of CD8 and programmed death-ligand 1 expression in patients with resectable non-small cell lung cancer | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41416-019-0398-5/MediaObjects/41416_2019_398_Fig2_HTML.png)
Prognostic impact of CD8 and programmed death-ligand 1 expression in patients with resectable non-small cell lung cancer | British Journal of Cancer
![The prognosis of non-small cell lung cancer patients according to endobronchial metastatic lesion | Scientific Reports The prognosis of non-small cell lung cancer patients according to endobronchial metastatic lesion | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-022-17918-1/MediaObjects/41598_2022_17918_Fig3_HTML.png)
The prognosis of non-small cell lung cancer patients according to endobronchial metastatic lesion | Scientific Reports
Tumor Treating Fields Plus Standard of Care Improved Overall Survival Among Patients With Metastatic Non-Small Cell Lung Cancer on Vimeo
![5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study - The Lancet Oncology 5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study - The Lancet Oncology](https://www.thelancet.com/cms/attachment/96376398-fbed-4daa-bd31-dd6b9854d8fc/gr3.jpg)
5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study - The Lancet Oncology
![EGFR tyrosine kinase inhibitor therapy for lung cancer treatments and their clinical outcomes: A cohort study in Taiwan EGFR tyrosine kinase inhibitor therapy for lung cancer treatments and their clinical outcomes: A cohort study in Taiwan](https://www.spandidos-publications.com/article_images/ol/18/6/ol-18-06-6090-g02.jpg)
EGFR tyrosine kinase inhibitor therapy for lung cancer treatments and their clinical outcomes: A cohort study in Taiwan
![Histological Grade: Analysis of Prognosis of Non-small Cell Lung Cancer After Complete Resection | In Vivo Histological Grade: Analysis of Prognosis of Non-small Cell Lung Cancer After Complete Resection | In Vivo](https://iv.iiarjournals.org/content/invivo/32/6/1505/F1.large.jpg)